AngioDynamics (NASDAQ:ANGO – Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided EPS guidance of -0.420–0.380 for the period, compared to the consensus EPS estimate of -0.410. The company issued revenue guidance of $282.0 million-$288.0 million, compared to the consensus revenue estimate of $284.4 million. AngioDynamics also updated its FY25 […]

Constellation Brands (NYSE:STZ – Get Free Report) issued an update on its FY25 earnings guidance on Thursday morning. The company provided earnings per share guidance of $13.60-13.80 for the period, compared to the consensus earnings per share estimate of $13.71. The company issued revenue guidance of $10.36-10.56 billion, compared to the consensus revenue estimate of […]

AngioDynamics (NASDAQ:ANGO – Get Free Report) issued its quarterly earnings data on Thursday. The medical instruments supplier reported ($0.11) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.04, Briefing.com reports. AngioDynamics had a negative return on equity of 4.91% and a negative net margin of 61.55%. The firm had […]

Constellation Brands (NYSE:STZ – Get Free Report) issued its quarterly earnings data on Thursday. The company reported $4.32 EPS for the quarter, topping the consensus estimate of $4.08 by $0.24, Briefing.com reports. The firm had revenue of $2.92 billion during the quarter, compared to the consensus estimate of $2.95 billion. Constellation Brands had a return […]

Duckhorn Portfolio (NYSE:NAPA – Get Free Report) is scheduled to announce its earnings results after the market closes on Monday, October 7th. Analysts expect the company to announce earnings of $0.09 per share for the quarter. Parties interested in registering for the company’s conference call can do so using this link. Duckhorn Portfolio Stock Performance […]

AngioDynamics (NASDAQ:ANGO – Get Free Report) issued an update on its FY25 earnings guidance on Thursday morning. The company provided EPS guidance of ($0.42)-($0.38) for the period, compared to the consensus EPS estimate of ($0.41). The company issued revenue guidance of $282-288 million, compared to the consensus revenue estimate of $284.37 million. AngioDynamics also updated […]

AbbVie (NYSE:ABBV – Get Free Report) updated its third quarter 2024 earnings guidance on Thursday. The company provided earnings per share guidance of 2.920-2.960 for the period, compared to the consensus earnings per share estimate of 2.950. The company issued revenue guidance of -. AbbVie also updated its FY 2024 guidance to 10.710-10.910 EPS. AbbVie […]

Conagra Brands (NYSE:CAG – Get Free Report) released its earnings results on Wednesday. The company reported $0.53 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.60 by ($0.07), Briefing.com reports. The company had revenue of $2.79 billion for the quarter, compared to the consensus estimate of $2.84 billion. Conagra Brands had […]

Constellation Brands (NYSE:STZ – Get Free Report) posted its quarterly earnings results on Thursday. The company reported $4.32 EPS for the quarter, beating the consensus estimate of $4.08 by $0.24, Briefing.com reports. Constellation Brands had a return on equity of 23.72% and a net margin of 22.70%. The firm had revenue of $2.92 billion during […]

Levi Strauss & Co. (NYSE:LEVI – Get Free Report) announced its earnings results on Wednesday. The blue-jean maker reported $0.33 EPS for the quarter, beating the consensus estimate of $0.31 by $0.02, Briefing.com reports. The business had revenue of $1.52 billion for the quarter, compared to the consensus estimate of $1.55 billion. Levi Strauss & […]

AngioDynamics (NASDAQ:ANGO – Get Free Report) released its quarterly earnings data on Thursday. The medical instruments supplier reported ($0.11) EPS for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.04, Briefing.com reports. The firm had revenue of $67.50 million for the quarter, compared to the consensus estimate of $67.93 million. AngioDynamics had a negative […]

AbbVie (NYSE:ABBV – Get Free Report) updated its third quarter earnings guidance on Thursday. The company provided earnings per share guidance of $2.88-2.92 for the period, compared to the consensus earnings per share estimate of $2.95. AbbVie also updated its FY 2024 guidance to 10.710-10.910 EPS. AbbVie Stock Down 0.6 % Shares of ABBV opened […]

DTE Energy (NYSE:DTE – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $6.54-6.83 for the period, compared to the consensus estimate of $6.69. DTE Energy also updated its FY 2024 guidance to 6.540-6.830 EPS. Wall Street Analysts Forecast Growth A number of research analysts […]

Lamb Weston (NYSE:LW – Get Free Report) issued an update on its FY25 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $4.15-4.35 for the period, compared to the consensus earnings per share estimate of $4.49. The company issued revenue guidance of $6.6-6.8 billion, compared to the consensus revenue estimate of […]

McCormick & Company, Incorporated (NYSE:MKC – Get Free Report) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $2.85-2.90 for the period, compared to the consensus estimate of $2.87. The company issued revenue guidance of +/-1% to ~$6.59-6.73 billion, compared to the consensus revenue […]

WEC Energy Group, Inc. (NYSE:WEC – Free Report) – Investment analysts at Zacks Research boosted their FY2024 earnings estimates for shares of WEC Energy Group in a research note issued to investors on Tuesday, October 1st. Zacks Research analyst R. Department now anticipates that the utilities provider will post earnings per share of $4.87 for […]